- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
The mutual funds he's telling investors to get into, and which ones he thinks they should avoid.
They trounced the fund pack in the first quarter, but many experts say it's not your best bet.
From choosing the wrong filing status to forgetting to sign your name, avoid these pitfalls.